Core Points - Semler Scientific, Inc. has announced it will not host a conference call or provide an earnings presentation for its Q3 2025 financial results due to a pending transaction with Strive, Inc. [1] - The company is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset, indicating a strategic shift in its financial management [3] - Semler Scientific plans to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025, around November 12, 2025 [2] Company Overview - Semler Scientific is a leader in medical devices and software aimed at combating chronic diseases, with a focus on early detection and monitoring [3] - The company's flagship product, QuantaFlo®, is FDA-cleared and provides rapid point-of-care testing for diagnosing peripheral arterial disease [3] - The company intends to strategically accumulate Bitcoin using proceeds from equity and debt financings, as well as cash flows from operations [3] Transaction Details - The proposed transaction with Strive, Inc. is expected to bring strategic and financial benefits, although specific details regarding the anticipated impact on future performance have not been disclosed [4][5] - A Registration Statement on Form S-4 has been filed with the SEC to register the Class A common stock to be issued in connection with the proposed transaction [8] - Stockholders of Semler Scientific will receive a definitive Information Statement/Proxy Statement/Prospectus to seek their approval for the proposed transaction [8]

Company Overview - Semler Scientific, Inc. is a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin [5] - In May 2024, Semler Scientific became the second U.S. publicly traded company to adopt a Bitcoin treasury strategy, intending to strategically accumulate Bitcoin using proceeds from equity and debt financings, as well as cash flows from operations [5] - The company is also a pioneer in developing and marketing technology products and services for evaluating and treating chronic diseases, with its flagship product, QuantaFlo®, being a rapid point-of-care test for cardiovascular diseases [5] Leadership Changes - Natalie Brunell has been appointed to the board of directors, reflecting Semler Scientific's commitment to its Bitcoin treasury strategy and strengthening its leadership within the Bitcoin community [1][2] - Eric Semler, chairman of Semler Scientific, emphasized that Brunell's insights will be instrumental in pursuing the company's Bitcoin treasury strategy and delivering long-term value to stockholders [2] Natalie Brunell's Background - Natalie Brunell is recognized as a top-rated podcast host and influential educator in the Bitcoin space, hosting the leading Bitcoin podcast 'Coin Stories' [3] - She has a background as an award-winning TV journalist and investigative reporter, holding a regional news Emmy for breaking news coverage and has experience as an adjunct professor [4]

Financial Highlights - Semler Scientific reported revenues of $56.3 million in FY2024 and $8.8 million in Q1 2025[11] - The company held 3,733 bitcoins as of May 12, 2025[10] - Semler Scientific acquired 3,808 bitcoins at a total cost of $340 million as of May 12, 2025[11] - The total market value of Semler Scientific's bitcoin holdings was $387.9 million as of May 12, 2025[11] - Semler Scientific had a cash, cash equivalents, and restricted cash balance of $9.9 million as of March 31, 2025[12] Bitcoin Strategy - Semler Scientific aims to create stockholder value through bitcoin accumulation[7] - The company strategically uses debt and equity securities issuances to accumulate bitcoin[7] - Semler Scientific's primary treasury reserve asset is bitcoin[11] - The company has an ATM authorization remaining of $438 million[25] Healthcare Business - Semler Scientific's healthcare business has historically been cash generative, which may support future bitcoin purchases[7] - The company is expanding product offerings and seeking a new 510(k) clearance[28]